An outpatient addiction treatment center can look busy while its financial performance becomes harder to explain. Patients move between levels of care, authorizations expire, attendance changes, and collections arrive after the treatment month. If you plan to sell an outpatient treatment center, the preparation challenge is connecting those moving parts. A buyer needs to understand what each program delivers, which services produce collectible revenue, and whether the operation can continue smoothly after ownership changes. That work starts with a clear picture of your IOP and PHP business.
Separate intensive outpatient programming, partial hospitalization, standard outpatient visits, medication services, and ancillary activities in the operating description. Identify the legal entity, physical location, license, payer enrollment, and clinical leadership associated with each. A shared brand does not establish that every location has the same permissions or that all revenue belongs to the entity being sold.
Program labels alone do not establish coverage. CMS’s March 2026 Medicare mental health booklet describes IOP eligibility in terms of needing at least nine hours of services weekly and PHP eligibility in terms of needing at least 20. Medicare also has provider-setting, certification, and treatment-plan requirements. These are Medicare criteria, not universal definitions for every commercial plan, state Medicaid program, or licensing authority. Review the rules that actually govern your revenue.
Keep opioid treatment program services distinct. An IOP may treat opioid use disorder without being a federally certified OTP, and medication prescribing alone does not make a practice an OTP. If your organization operates both, separate their approvals and financial reporting. See the dedicated discussion of selling an opioid treatment program for that ownership-transfer workstream.
Build a monthly bridge from admissions and active census to scheduled services, attended services, documented billable activity, submitted claims, allowed amounts, and cash receipts. Define each measure. Average census may count active patients who attended very different numbers of sessions. Authorizations describe permitted services; they do not show that treatment occurred or that the resulting claim was paid.
Consider a hypothetical month with 100 active IOP patients and 80 with current payer authorizations. Neither number establishes revenue. The review still needs actual attendance, documented covered services, claim submission, adjudication, and collections. Avoid multiplying the entire roster by the published daily rate. Reconcile differences explicitly, including missed visits, incomplete documentation, exhausted authorizations, denials, and contractual adjustments.
Use service-month cohorts so buyers can follow how an older month ultimately collected without confusing it with today’s cash receipts. Recent months may still be developing; label them accordingly. Reconcile the billing system, general ledger, and bank activity, then explain material differences. The sister-site guide to addiction treatment reimbursement due diligence provides the broader review framework. Your outpatient preparation should make that review traceable at the program level.
A consolidated income statement can hide a strong IOP supporting a new PHP or one location subsidizing another. Prepare consistent monthly views across four dimensions:
Explain changes in the mix before presenting a trend as improvement. Higher revenue per attended day could reflect a shift toward PHP, a different payer mix, or fewer contractual adjustments. That is different from a rate increase for unchanged services. Keep the definitions consistent enough for a buyer to reproduce the comparison.
Organize records around the questions that drive an IOP or PHP assessment. Use a dated index and an accountable internal owner for each category:
Document gaps candidly. A corrective-action log should identify the issue, responsible person, evidence needed, and current status. Label an item complete only when the underlying fix can be demonstrated. A policy revision alone may not establish that daily practice has changed.
Break admissions out by source over time: hospitals, other treatment programs, clinicians, community relationships, direct inquiries, and marketing channels. Show the path from inquiry to assessment and admission without exposing patient identities. Measure concentration and explain seasonal changes. A large inquiry count is less informative when few people are clinically appropriate for the services available.
For internally generated step-down admissions, show the actual history of transitions into IOP or PHP and the clinical process guiding them. Do not present all residential discharges as a captive future census. If a referring program is outside the sale, a buyer needs to understand who controls the relationship and whether it is documented. Patient choice and appropriate placement remain central.
Have counsel review arrangements involving referral sources, marketing, housing, transportation, or other benefits. The HHS Office of Inspector General’s compliance guidance describes federal risk areas; applicable addiction treatment-specific and state laws also need review. An attractive acquisition model cannot depend on questionable admissions practices. Track legitimate outreach effectiveness while keeping referral incentives and treatment decisions under appropriate compliance oversight.
Room capacity and open calendar slots do not establish how many patients a program can responsibly serve. Show the people and processes supporting the current schedule:
Support quality statements with defined measures and clear denominators. Completion rates, follow-up participation, and patient-reported results need consistent definitions, measurement periods, and an explanation of missing data. Do not label every discharge a successful completion or infer clinical quality from revenue growth. Buyers should be able to understand what the reported measure actually captures.
Create a responsibility matrix for each license, payer relationship, enrollment, lease, and vendor contract. Have counsel and the relevant authority or counterparty confirm the notice, consent, application, or approval required for the proposed structure. Do not assume an equity sale avoids every requirement or an asset sale automatically transfers a contract. Assign responsibility for patients mid-authorization, scheduled sessions, unresolved claims, and billing-system access during the transition.
Plan record access separately from system access. The HHS Part 2 fact sheet outlines confidentiality protections for covered substance use disorder records, including requirements applicable from February 16, 2026. Have privacy counsel determine the appropriate basis and safeguards for diligence and transition disclosures. Use appropriately aggregated or de-identified information where possible; avoid dropping identifiable patient exports into a general buyer folder.
Prioritize issues that affect whether the program can operate and collect after closing: unresolved service authority, material payer questions, unsupported revenue, critical staffing gaps, and transition dependencies. Then address reporting improvements that make the business easier to evaluate. Have your accountant distinguish operating performance from cash timing and the proposed treatment of receivables. The separate article on working capital in a treatment center sale covers closing adjustments. If outside coordination would help, compare the scope and experience of an addiction treatment sell-side advisor. Avoid reshaping clinical schedules solely to improve a sale presentation; preparation should strengthen reliable operations.
Bring clinical operations, revenue cycle, and finance together to explain one complete month for each material program. Resolve conflicting definitions before expanding the analysis. For the overall transaction framework, read the sister-site guide to selling an addiction treatment center. Keep this workstream focused on proving how your outpatient business runs.
Tony Siebel is the Founder and Managing Director of Olympic M&A. His background includes corporate development and physician-practice acquisitions at MDVIP, as well as serving as Vice President and Associate Partner at Stoneridge Partners, including work in its Behavioral Health Division.
Olympic M&A advises founders and healthcare business owners on transactions with private equity groups and strategic acquirers. Learn more about the firm’s behavioral health advisory services and discuss the scope of support appropriate for your business.
Contact Olympic M&A | info@olympicma.com | 502.360.8320